InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Estepan Ian Michael, Chief Financial Officer. Officer active across 1 company, notably Sarepta Therapeutics, Inc.. Aggregated, 23 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €992k. History available since 8 September 2021. The latest transaction was filed on 11 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Estepan Ian Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
1,097 shares@ US$17.030.7% of flowCommon StockSEC:0001193125-26-106710:0
1,036 shares@ US$16.950.7% of flowCommon StockSEC:0001193125-26-102701:0
8,125 sharesCommon StockSEC:0001193125-26-089432:0
2,069 shares@ US$13.711.1% of flowCommon StockSEC:0001193125-26-084265:0
13,187 shares@ US$22.3111.4% of flowCommon StockSEC:0001193125-25-325383:0
93,875 shares0Common StockSEC:0001193125-25-197423:0
5,500 sharesCommon StockSEC:0000950170-25-037519:0
17,500 sharesCommon StockSEC:0000950170-25-036695:0
1,370 shares@ US$101.346.5% of flowCommon StockSEC:0000950170-25-035003:0
557 shares@ US$103.772.7% of flowCommon StockSEC:0000950170-25-032760:0
14,267 shares@ US$12.008.0% of flowCommon StockSEC:0000950170-25-011959:0
250 shares0Common StockSEC:0000950170-24-141250:0
5,985 shares@ US$137.3636.1% of flowCommon StockSEC:0000950170-24-103070:0
6,250 sharesCommon StockSEC:0000950170-24-077519:0
526 shares@ US$120.492.8% of flowCommon StockSEC:0000950170-24-029529:0
1,389 shares@ US$125.327.8% of flowCommon StockSEC:0000950170-24-027498:0
365 shares@ US$126.192.1% of flowCommon StockSEC:0000950170-24-026605:0
744 shares@ US$153.195.3% of flowCommon StockSEC:0001209191-23-018020:0
1,370 shares@ US$157.219.9% of flowCommon StockSEC:0001209191-23-017408:0
378 shares@ US$147.572.6% of flowCommon StockSEC:0001209191-23-016055:0
1,308 shares@ US$79.204.2% of flowCommon StockSEC:0001209191-22-017347:0
376 shares@ US$75.051.1% of flowCommon StockSEC:0001209191-22-014408:0
1,623 shares@ US$78.294.8% of flowCommon StockSEC:0001209191-21-055383:0
23 of 23 declarations
About Estepan Ian Michael
Estepan Ian Michael is Directeur Financier and Chief Operating Officer at Sarepta Therapeutics, Inc. Across 23 filings in total, the 23 sampled filings span from 2021-09-09 to 2026-03-13, with EUR 0 of buys and EUR 992223 of sells, and the modal transaction nature is Retenue fiscale.
